Evidence map›Paper›PMID 32587151›Full record

GuidelineIndian journal of ophthalmology2020

Preferred practice guidelines for glaucoma management during COVID-19 pandemic.

Sushma Tejwani, Dewang Angmo, Barun Kumar Nayak, Namrata Sharma, Mahipal S Sachdev, Tanuj Dada, Rajesh Sinha, Prepared in Association with the AIOS and GSI Expert Group, Composition of the All India Ophthalmological Society (AIOS) and Glaucoma Society of India (GSI) Expert Group includes the Writing Committee (as listed) and the following members: Devindra Sood, Arup Chakrabarti, Chandrima Paul, Chitra Ramamurthy, Harsh Kumar, Jatinder Singh Bhalla, Krishna Das R, Manav Deep Singh, Murali Ariga, R. Venkatesh, Shahinur Tayab, Sirisha Senthil, Suresh Kumar, Surinder Singh Pandav, Amit Porwal, Ankur Sinha

Open access · diamondAbstract readPractice Guideline
In one paragraph

Guideline in Indian journal of ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. How glaucoma care changed for the better after the pandemic.Current opinion in ophthalmology · 2022
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Does ocular tissue contain SARS CoV-2?Indian journal of ophthalmology · 2021
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sushma TejwaniDepartment of Glaucoma, Narayana Nethralaya-2, Bangalore, Karnataka, India.
Dewang AngmoDr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Barun Kumar NayakP. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
Namrata SharmaDr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Mahipal S SachdevCentre for Sight, New Delhi, India.
Tanuj DadaDr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Rajesh SinhaDr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Prepared in Association with the AIOS and GSI Expert Group
Composition of the All India Ophthalmological Society (AIOS) and Glaucoma Society of India (GSI) Expert Group includes the Writing Committee (as listed) and the following members: Devindra Sood, Arup Chakrabarti, Chandrima Paul, Chitra Ramamurthy, Harsh Kumar, Jatinder Singh Bhalla, Krishna Das R, Manav Deep Singh, Murali Ariga, R. Venkatesh, Shahinur Tayab, Sirisha Senthil, Suresh Kumar, Surinder Singh Pandav, Amit Porwal, Ankur Sinha
All India Institute of Medical Sciences · INNarayana Nethralaya · INP. D. Hinduja Hospital and Medical Research Centre · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has threatened the humanity at a global level to a large extent by the burden of the disease with significant mortality and to a certain extent as a byproduct of the necessary efforts to contain the same. There is a significant impact on the health care system, as we not only have to contain pandemic, but continue to treat our non-COVID-19 patients in a safe and responsible manner. Ophthalmology practice in general and glaucoma in particular needs certain modifications and additional precautions while examining as well as managing these patients keeping their and our safety in mind. As the lockdown relaxations are in vogue we need to learn how to deal with our regular patients as well in addition to emergency care. This paper presents the consensus-based guidelines by an expert panel on how to restart glaucoma practice during this COVID-19 time. These guidelines will be applicable across the country and should help ophthalmologists and glaucoma specialist to restart their practices while safeguarding the patients and their own selves from getting infected.

Indexed as

BetacoronavirusConsensusPandemicsCoronavirus InfectionsCOVID-19Disease ManagementDisease Transmission, InfectiousGlaucomaHumansOphthalmologyPneumonia, ViralSARS-CoV-2ConsensusCOVID-19glaucomaglaucoma guidelinespandemicpreferred practice with COVID-19

Identifiers

PMID32587151
PMCPMC7574094
OpenAlexW3037067857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.